S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/RA Capital Management/Q4 2020

RA Capital Management

Periodo: Q4 2020 Β· Depositato: 2021-02-16
Vedi su SEC EDGAR β†—
AUM
$7.15B
Valore totale del portafoglio
Posizioni
82
Titoli dichiarati
Prima Posizione
ASND
13.7% $978.2M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-02-16) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
ASNDASCENDIS PHARMA A S$978.2M13.67%$166.78$274.50+64.6%
13.7%
TGTXTG THERAPEUTICS INC$451.8M6.32%$52.02$53.31+2.5%
6.3%
NVAXNOVAVAX INC$422.5M5.91%$111.51$9.74-91.3%
5.9%
NKTXNKARTA INC$344.6M4.82%$61.47$3.22-94.8%
4.8%
FMTXFORMA THERAPEUTICS HLDGS INC$314.5M4.40%β€”β€”
4.4%
ARVNARVINAS INC$311.9M4.36%$84.93$8.39-90.1%
4.4%
CCXICHEMOCENTRYX INC$295.8M4.13%β€”$19.10
4.1%
AVIRATEA PHARMACEUTICALS INC$224.3M3.14%$41.78$4.98-88.1%
3.1%
ITOSITEOS THERAPEUTICS INC$149.4M2.09%β€”β€”
2.1%
KNTEKINNATE BIOPHARMA INC$142.9M2.00%β€”β€”
2.0%
AXSMAXSOME THERAPEUTICS INC$134.9M1.89%$81.47$244.31+199.9%
1.9%
KROSKEROS THERAPEUTICS INC$132.3M1.85%$70.54$11.26-84.0%
1.9%
PHATPHATHOM PHARMACEUTICALS INC$127.1M1.78%$33.22$11.20-66.3%
1.8%
RYTMRHYTHM PHARMACEUTICALS INC$124.2M1.74%$29.73$114.17+284.0%
1.7%
TVTXTRAVERE THERAPEUTICS INC$124.2M1.74%$27.25$56.92+108.9%
1.7%
IMGNIMMUNOGEN INC$118.8M1.66%β€”β€”
1.7%
RCKTROCKET PHARMACEUTICALS INC COM$117.1M1.64%$54.84$3.84-93.0%
1.6%
ETNB89BIO INC$115.4M1.61%β€”β€”
1.6%
ZGNXZOGENIX INC$106.9M1.49%β€”β€”
1.5%
PMVPPMV PHARMACEUTICALS INC$105.2M1.47%$61.51$1.22-98.0%
1.5%
OLMAOLEMA PHARMACEUTICALS INC$103.4M1.45%$48.08$12.64-73.7%
1.4%
ADVMADVERUM BIOTECHNOLOGIES INC$103.0M1.44%β€”β€”
1.4%
MGNXMACROGENICS INC$100.0M1.40%$22.86$4.71-79.4%
1.4%
PCVXVAXCYTE INC$98.6M1.38%$26.57$58.39+119.8%
1.4%
IGMSIGM BIOSCIENCES INC$86.8M1.21%β€”β€”
1.2%
BDTXBLACK DIAMOND THERAPEUTICS INC$83.0M1.16%$32.05$2.01-93.7%
1.2%
SPRYSILVERBACK THERAPEUTICS INC$80.7M1.13%$46.34$8.56-81.5%
1.1%
TRILLIUM THERAPEUTICS INC$77.8M1.09%β€”β€”
1.1%
SLDBSOLID BIOSCIENCES INC$75.6M1.06%$113.70$10.84-90.5%
1.1%
KALAKALA PHARMACEUTICALS INC$73.7M1.03%$16950.00$1.68-100.0%
1.0%

AttivitΓ  Trimestre su Trimestre

Q4 2020 vs. Q3 2020

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
AVIRATEA PHARMACEUTICALS INC$224.3M-88.1%
KNTEKINNATE BIOPHARMA INC$142.9M
TVTXTRAVERE THERAPEUTICS INC$124.2M+108.9%
RCKTROCKET PHARMACEUTICALS INC COM$117.1M-93.0%
OLMAOLEMA PHARMACEUTICALS INC$103.4M-73.7%
SPRYSILVERBACK THERAPEUTICS INC$80.7M-81.5%
FPRXFIVE PRIME THERAPEUTICS INC$72.9M
CRISCURIS INC$63.1M

Posizioni Chiuse (8)

TickerEmittenteNozionale
MCRBSERES THERAPEUTICS INC$134.5M
EIDXEIDOS THERAPEUTICS INC$109.3M
RTRXRETROPHIN INC$85.6M
RLMDRELMADA THERAPEUTICS INC$29.4M
PRVLPREVAIL THERAPEUTICS INC$19.5M
FSDCFS DEV CORP$11.2M
VSTMXXXXVERASTEM INC$9.8M
ARYBUARYA SCIENCES ACQUISITION CORP$7.7M

Aumentate (4)

TickerEmittenteNozionaleVar. AzioniDal Deposito
NVAXNOVAVAX INC$292.6M+216.1%-91.3%
IMGNIMMUNOGEN INC$93.5M+161.6%
SLDBSOLID BIOSCIENCES INC$66.3M+118.3%-90.5%
ADVMADVERUM BIOTECHNOLOGIES INC$6.1M+1.0%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ADAPYADAPTIMMUNE THERAPEUTICS PLC$-76.9M-77.9%
CRNXCRINETICS PHARMACEUTICALS INC$-28.5M-75.8%
VXRTVAXART INC$-56.2M-74.6%
OCULOCULAR THERAPEUTIX INC$-5.2M-72.5%
ALECALECTOR INC$-13.7M-55.3%
PCVXVAXCYTE INC$-162.3M-29.8%+119.8%
RYTMRHYTHM PHARMACEUTICALS INC$12.8M-18.7%+284.0%
AXSMAXSOME THERAPEUTICS INC$-10.1M-18.7%+199.9%
← Torna agli Hedge Fund